ArticleProceedings of the National Academy of Sciences of the United States of America2006

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752.

Gromoslaw A Smolen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.